Publications

Research powered by Signios

Peer-reviewed studies where our sequencing and multi-omic workflows helped drive discovery. Filter by technique or year to explore.

200+

citations of our work

50+

peer-reviewed journals

15+

years of collaboration

Year
Showing 0 publications

2026

Cancers modulate processing and presentation of p53 neoantigens to evade T cell detection

Koji Haratani, Bruce Reinhold, Jonathan S Duke-Cohan, et al.

2026

Leptomeningeal collaterals constitute an immune-responsive vascular niche in ischemic stroke

Jing Ju, Kylee Smith, Collin E Tanchanco, et al.

2026

Unsupervised transcriptomic analysis of paired pre- and post-treatment specimens reveals divergent chemoimmunomodulatory induction trajectories in breast cancer

Iasmim Lopes de Lima, Elizabeth Molchan, Kathleen H Streeks, et al.

2026

RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation

Pushpamali De Silva, Samantha Fitzgerald, Jules Cazaubiel, et al.

2026

The antiretroviral drug emtricitabine increases kynurenine : tryptophan ratio, aryl hydrocarbon receptor activation, and cellular senescence in female mice

Alok Tripathi, Shabiha Sultana, Sagar Vyavahare, et al.

2026

From in silico prediction to experimental validation: Identification of drugs and novel synergistic combinations that inhibit growth of inflammatory breast cancer cells

Esraa A Salim, Xiaojia Ji, Michael Tarpley, et al.

2026

Emerin loss of function inhibits MyoD-driven differentiation of human iPSCs into skeletal myotubes

Tracy A Knight, Jessica Mella, Daniel Chen, et al.

2026

CDK8/19 inhibition prevents adaptive resistance to CDK4/6 inhibitors in vitro and in vivo

Zachary T Mack, Margarita Yastrebova, Chang-Uk Lim, et al.

2026

Elevated dNTP Pool Levels Impair Homologous Recombination and Enhance Glioblastoma Sensitivity to Irradiation and Temozolomide

Dominique Monroe, Mercy Kehinde-Ige, Arilyn Williams, et al.

2026

Stimulation of oncogene-specific tumor infiltrating T-cells through combined vaccine and αPD1 enable sustained anti-tumor responses against established HER2 Breast Cancer

Erika J Crosby, Chaitanya R Acharya, Anthony-Fayez Haddad, et al.

Published with Signios? Let us know

If our workflows contributed to your research, we’d love to feature your paper here and share it with our community.